about
Activation of blood coagulation in cancer: implications for tumour progressionExosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functionsL-selectin mechanochemistry restricts neutrophil priming in vivo.Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.Tissue factor in tumor microenvironment: a systematic reviewCirculating microparticles in patients with antiphospholipid antibodies: characterization and associations.Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study.Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury.Procoagulant microparticles in dogs with immune-mediated hemolytic anemiaHypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model.Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.Bench to bedside: new developments in our understanding of the pathophysiology of thrombosis.The emerging roles of microvesicles in liver diseases.Toward routine detection of extracellular vesicles in clinical samples.Microparticles as biomarkers of venous thromboembolic events.Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis.Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.Caspase inhibition reduces hepatic tissue factor-driven coagulation in vitro and in vivo.
P2860
Q26998742-4D562688-A324-4D18-A29F-47EB4AACC74CQ30597581-418C7CAB-0F16-4C0B-B1F2-F0B9A9FD7663Q30851884-93175E1E-608B-4B36-908E-E7796D881C9CQ33432917-B7C5C69B-4E30-4E70-B1B8-3C658F25AB44Q34544801-83C04426-6922-4F2A-AF22-05C8A2237FA0Q34749444-169B1F54-6E5E-4034-A7A0-1DC46166D181Q36079937-9AAC5C38-3AD1-41F9-AB32-F4169BE20E94Q36405104-56DDF3FC-D1E9-4ED9-81A0-8985A92CF70EQ36974952-EBBCDAC8-E87E-42C3-B709-661AB5FF755CQ37001337-630EF055-82EA-4B90-9911-5F436325BADBQ37169096-503F9171-8CB5-4B51-AE55-2F0A8CB1D10AQ38082468-B3CAF25A-9609-4F0E-8A27-A9B6118D9F1CQ38184831-616DE760-17CF-40AE-9DC9-5633760390ACQ38205945-D26519ED-DC72-47C2-A826-ECFFD1B78A92Q38874997-D9347C76-8896-4DED-8BA5-5467B1A71E61Q39000052-9D276672-94A3-4ADA-A783-B92E0BDBF0F8Q41071373-35E92C75-F48A-4940-8865-159A0E4AC8F2Q41124163-F1939742-3F72-454B-913B-E57927037B47Q42361529-54C7E41F-965B-4D25-9CE7-6AA341C368FCQ48573415-2759C247-7E38-4AC8-8E2D-6994CC7475C2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Microvesicles as risk markers for venous thrombosis.
@en
type
label
Microvesicles as risk markers for venous thrombosis.
@en
prefLabel
Microvesicles as risk markers for venous thrombosis.
@en
P2860
P356
P1476
Microvesicles as risk markers for venous thrombosis.
@en
P2860
P304
P356
10.1586/EHM.12.74
P577
2013-02-01T00:00:00Z